Matthew J. Gilroy is a partner in the firm’s New York office, and a member of the firm’s Mergers & Acquisitions practice.
Mr. Gilroy regularly represents acquirors, targets, buyout groups, boards of directors, special committees, investment banks, investors and shareholder groups in complex domestic and cross-border acquisition, merger and restructuring transactions (both negotiated and unsolicited) in a broad range of industries, including Eli Lilly & Company, American International Group, Inc., Leucadia National Corporation, Cedar Fair, L.P., Cardinal Health, Inc., Davita, Inc., Global Tower Partners, Hollinger, Inc., Macquarie, Providence Equity Partners, Citigroup and Irving Place Capital.
Mr. Gilroy also counsels clients on a broad range of corporate, securities and business-related matters, including fiduciary duties, corporate governance, disclosure issues and compliance matters, as well as defensive measures, takeover tactics, proxy fights and other contests for corporate control.
Recent Experience:
- American Realty Capital Properties, Inc. in its approximately $9 billion unsolicited offer to purchase Cole Credit Property Trust III, Inc.
- American Realty Capital Trust III in $2.2 billion acquisition by American Realty Capital Properties.
- Medicis Pharmaceutical Corporation in its $2.6 billion sale to Valeant Pharmaceuticals International
- Leucadia in its merger with global investment banking firm Jefferies Group in which it had a 28.6% stake.
- Eli Lilly and Company in its acquisition of ChemGen Corp.
- Leucadia National Corporation in its acquisition of National Beef Packing Company for $868 million.
- Eli Lilly and Company in its acquisition of Avid Radiopharmaceuticals for up to $800 million.
- American International Group, Inc. in its sale of AIG Rail Services, Inc. to an affiliate of Perella Weinberg Partners.
- Cedar Fair, L.P. in its proposed $2.4 billion acquisition by an affiliate of Apollo Global Management.
- Irving Place Capital in its $412 million acquisition of Thermadyne Holdings Corporation.
- American International Group, Inc. in its sale of a $16 billion preferred interest in American International Assurance Company to the Federal Reserve Bank of New York.
- American International Group, Inc. in its sale of a $9 billion preferred interest in American Life Insurance Company to the Federal Reserve Bank of New York.
- Providence Equity Partners Inc., Ontario Teachers' Pension Plan Board and Madison Dearborn Partners, LLC in its proposed $48.5 billion going private acquisition of BCE Inc. (Bell Canada).
- Cardinal Health, Inc. in the spin-off of its Clinical and Medical Products businesses.
- Yildiz Holding AS in its $850 million acquisition of Godiva Chocolatier Inc. from Campbell Soup Company.
- Macquarie Infrastructure Partners and Macquarie Communications Infrastructure Group in its $1.425 billion acquisition of Global Tower Partners from Blackstone.
- Lone Star Technologies in its $2.1 billion sale to United States Steel Corp.
- Florida Rock Industries Inc. in its $4.6 billion sale to Vulcan Materials Company.
- Omnicare, Inc. in its $490 million hostile acquisition of NCS HealthCare, Inc.
- Lottomatica S.p.A. in its $4.5 billion acquisition of GTECH Holding Corporation.
- Houghton Mifflin Riverdeep Group plc in its $4 billion acquisition of the Harcourt US Schools Education business of Reed Elsevier Group plc.
- The Walt Disney Company in its $5.3 billion acquisition of Fox Family Worldwide, Inc.
- The MONY Group in its $2.3 billion sale to AXA Financial.
- LifePoint Hospitals, Inc. in its $1.7 billion sale to Province Healthcare Company.
Mr. Gilroy has authored several articles on the fiduciary duties of corporate directors and developments in the mergers and acquisitions area. In 2006, Mr. Gilroy received a Burton Award for Legal Achievement for his article, "Taking a Hard Look at Poison Pills" (New York Law Journal, November 7, 2005).
Mr. Gilroy received a B.S. from The Wharton School of the University of Pennsylvania in 1996 and a J.D., cum laude, from Georgetown University Law Center in 1999.